Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in Patients with Focal Segmental Glomerulosclerosis and in Patients From All Four Cohorts of PHOENIX February 20, 2019 - NASDAQ Companies 0 » View More News for February 20, 2019
